Patrick Vallance
More late-stage anguish for GSK heart drug
May 14, 2014Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart
GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
